Download the free Kindle app and start reading Kindle books instantly on your smartphone, tablet, or computer - no Kindle device required.
Read instantly on your browser with Kindle for Web.
Using your mobile phone camera - scan the code below and download the Kindle app.
OK
Talking Back to Ritalin: What Doctors Aren't Telling You About Stimulants for Children Hardcover – January 1, 1998
- Print length401 pages
- LanguageEnglish
- PublisherCommon Courage Pr
- Publication dateJanuary 1, 1998
- Dimensions6.5 x 1.25 x 9.5 inches
- ISBN-101567511295
- ISBN-13978-1567511291
The Amazon Book Review
Book recommendations, author interviews, editors' picks, and more. Read it now
Customers who viewed this item also viewed
Editorial Reviews
Review
"Every child needs a hero--a champion who will speak truth to power. That hero is Peter Breggin. When he writes on behalf of children and caring parents, the world should stand up and take notice. This book is packed with information needed by anyone who is considering prescribing psychiatric drugs to children." -- Jeffrey Moussaieff Masson, Ph.D, former projects director of the Freud Archives and author of Dogs Never Lie about Love and When Elephants Weep
"I am a mother first and a doctor second... The principles in this book help us as parents to empower our children to be successful in life." -- Sharon A. Collins, MD, pediatrician
About the Author
Product details
- Publisher : Common Courage Pr (January 1, 1998)
- Language : English
- Hardcover : 401 pages
- ISBN-10 : 1567511295
- ISBN-13 : 978-1567511291
- Item Weight : 1.65 pounds
- Dimensions : 6.5 x 1.25 x 9.5 inches
- Best Sellers Rank: #655,976 in Books (See Top 100 in Books)
- #308 in Children's Learning Disorders
- #514 in Pediatrics (Books)
- #1,186 in Pharmacology (Books)
- Customer Reviews:
About the author

Peter R. Breggin MD is known as “The Conscience of Psychiatry” for his many decades of successful reform work in the mental health field, but has now turned his attention to the misuse of science surrounding COVID-19 and its origins in what he and his coauthor Ginger Breggin are calling "global predators." He is currently the medical and psychiatric expert for an injunction against the governor of Ohio for oppressing the citizens with unending emergency decrees related to COVID-19. Dr. Breggin and his wife Ginger R. Breggin have written COVID-19 and the Global Predators: We are the Prey.
Dr. Breggin is a Harvard-trained psychiatrist and former full-time Consultant at the National Institute of Mental Health (NIMH) and part-time for the Federal Aviation Administration (FAA). He has been approved as a medical expert in over 100 legal cases in state and federal courts on issues relating to adverse drug effects, drug approval, the pharmaceutical industry, and the FDA. He is the author of two dozen medical, scientific, and best-selling popular books, as well as dozens of scientific articles.
Peter R. Breggin, MD, is a Harvard-trained psychiatrist and former full-time consultant at NIMH. He is in private practice in Ithaca, New York, and is the author of dozens of scientific articles and more than twenty books. Some of his many books include Toxic Psychiatry, Talking Back to Ritalin, The Antidepressant Fact Book, and The Heart of Being Helpful: Empathy and the Creation of a Healing Presence, and, with co-author Ginger Breggin, Talking Back to Prozac. His most recent publications include Medication Madness: The Role of Psychiatric Drugs in Cases of Violence, Suicide, and Crime (2008) and Brain-Disabling Treatments in Psychiatry: Drugs, Electroshock and the Psychopharmaceutical Complex, Second Edition (SPC, 2008). His two newest psychiatric books are Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients and their Families (SPC, 2013) and Guilt, Shame, and Anxiety: Understanding and Overcoming Negative Emotions (Prometheus, 2014). Dr. Breggin is the founder and director of The Center for the Study of Empathic Therapy, Education and Living (www.EmpathicTherapy.org) His professional website is www.breggin.com.
Customer reviews
Customer Reviews, including Product Star Ratings help customers to learn more about the product and decide whether it is the right product for them.
To calculate the overall star rating and percentage breakdown by star, we don’t use a simple average. Instead, our system considers things like how recent a review is and if the reviewer bought the item on Amazon. It also analyzed reviews to verify trustworthiness.
Learn more how customers reviews work on AmazonReviews with images
-
Top reviews
Top reviews from the United States
There was a problem filtering reviews right now. Please try again later.
It is easy to see why stimulants dominate the treatment of ADHD. Drug companies spend over $20 billion a year on promotion - more than they spend on research.What does this money buy them? David Healy, internationally known psychiatric researcher and writer, claims about 50 percent of all psychiatric journal articles are ghost written by employees of drug companies, and that 30% of The American Psychiatric Association's income comes from drug company subsidies, grants and advertising. Around 70 percent of all drug research is funded by the drug companies themselves, and most of the rest, funded by the government, is heavily influenced by drug companies' extensive lobbying machinery.
Major journals (including The New England Journal of Medicine and Lancet) have lamented the control of research and publishing by drug company money: The New England Journal of Medicine editorialized, stating they could hardly find reviewers for their psychiatric drug articles who did not have conflicts of interest due to financial ties with drug companies. Studies funded by drug companies, that don't support the companies' drugs, are rarely published.
The bottom line: professionals and the public are bombarded with a stream of "research" and "information" financed and spun by the people who make and sell these drugs. The conflict of interest is palpable.
Many people lack access to effective non-drug ways to deal with "ADHD." But this is no proof that the drugs are especially effective and safe - it just shows the advantage of having billions of dollars to finance and promote the drugs.
I have a challenge for readers who dismiss Breggin's book: Read half a dozen responsible critiques of biopsychiatry and psychiatric drugs. Try David Healy's The Creation of Psychopharmacology, also Healy's Let Them Eat Prozac (soon to come out in the U.S.), Robert Whitaker's Mad in America, Glenmullen's Prozac Backlash, Fisher and Greenberg's From Placebo to Panacea - Putting Psychiatric Drugs to the Test, and Elliott Valenstein's Blaming the Brain - The Truth About Drugs and Mental Health.
These are not works by new agers who think crystals heal schizophrenia. They are by respected academics, researchers and clinicians (and not all of them, especially Healy and Glenmullen, are against psychiatric drugs).
But read these books, and note the claims and evidence they cite about the drugs. Now, here's the challenge: look in mainstream psychiatric literature for any serious attempt to address these claims. I've read over forty books, pro and con, on psychiatric drugs - and I've yet to find pro-drug literature that addresses 98% of these arguments, not in general, and not point by point.
This is a matter of informed consent. See if Peter Breggin's words in Toxic Psychiatry are not at least very plausible: "In the world of modern psychiatry claims can become truth, hopes can become achievements and propaganda is taken as science".
Yes, Breggin is angry. He pulls no punches and gives no quarter. But he deserves serious consideration - he has been qualified as an expert witness in numerous product liability cases against drug companies around the country. Try to find, anywhere, point by point refutations of the specific claims he makes in this book. Except for a few points, biopsychiatry's silence on Breggin's claims is deafening. Ask an "authority" on ADHD whether, as Breggin claims, the pannel of experts at the NIH Consensus Conference on ADHD DID or DID NOT conclude in their final report, "..there are no data to indicate that ADHD is due to a brain malfunction," and ask the "authority" who it was that later took it upon himself to edit that statement to muddle the wording, but without changing its bottom line. And ask if it is true that the conference organizer, Peter Jensen, later admitted in a 2000 article that the experts at this conference found NO proof that "ADHD reflects a disordered state."(See Breggin, page 16).
If, after looking into the issue, you decide to give your child Ritalin, so be it. But each parent, child and professional deserves to know the whole story - something you will not get reading standard psychiatric literature.





